CD40 in clinical inflammation: From multiple sclerosis to atherosclerosis

Developmental Immunology

Volumn 6, Issue 3-4, 1998, Pages 215-222

  Laman, Jon D ^a,b   De Boer, Mark ^c   'T Hart, Bert A ^d  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Pangenetics   (Netherlands)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Accessory molecules; Costimulation; Immunocytochemistry; Macrophages

Indexed keywords

ANTIBODY; CD40 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 12; INTERLEUKIN 4;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ATHEROSCLEROSIS; B LYMPHOCYTE; CONFERENCE PAPER; DENDRITIC CELL; FIBROBLAST; HELPER CELL; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031771180     PISSN: 10446672     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/69628     Document Type: Conference Paper

References (54)

1. Alderson M.R., Armitage R.J., Tough T.W., Strockbine L., Fanslow W.C., and Spriggs M.K., (1993). CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669-674.
2. Armant M., Rubio M., Delespesse G., and Sarfati M. (1995). Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J. Immunol. 155: 4868-4875.
3. Borrow P., Tishon A., Lee S., Xu J., Grewal I.S., Oldstone M.B.A., and Flavell R.A. (1996). CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183: 2129-2142.
4. Campbell K., Ovendale P.J., Kennedy M.K., Fanslow S.G., Reed S.G., and Maliszewski C.R. (1996). CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289.
5. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. (1996). Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752.
6. Chiang C-S., Powell H.C., Gold L.H., Samimi A., and Campbell L. (1996). Marcophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97: 1512-1524.
7. Dollery C.M., McEwan J.R., and Henney A.M. (1995). Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77: 863-868.
8. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., and Noelle R.J. (1993). Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330.
9. Early G.S., Zhao W., and Burns C.M. (1996). Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black × New Zealand White mice. Response correlates with the absence of an antiantibody response. J. Immunol. 157: 3159-3164.
10. Foy T.M., Page D.M., Waldschmidt T.J., Schoneveld A., Laman J.D., Masters S.R., Tygrett L., Ledbetter J.A., Aruffo A., Claassen E., Xu J., Flavell R.A., Ohen S., Hedrick S.M., and Noelle R.J. (1995). An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182: 1377-1388.
11. Fries K.M., Sempowski G.D., Gaspari A.A., Blieden T., Looney R.J., and Phipps R.P. (1995). CD40 expression by human fibroblasts. Clin. Immunol. Immunopathol. 77: 42-51.
12. Galis Z.S., Sukhova G.K., Lark M.W., and Libby P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
13. Gerritse K., Deen C., Fasbender M., Ravid R., Boersma W.J.A., and Claassen E. (1994). The involvement of specific anti-myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J. Neuroimmunol. 49: 153-159.
14. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J.A., and Claassen E. (1996). CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 2499-2504.
15. Gerritse K., Slierendrecht B., Deen C., Fasbender M., Boersma W.J.A., and Claassen E. (1993). In situ detection of specific antimyelin basic protein antibody forming cells with horseradish peroxidase myelin basic protein conjugates. EOS J. Immunol. Immunopharmacol. 13: 63-65.
16. Green K.A., Crassi K.M., Laman J.D., Schoneveld A., Strawbridge R.R., Foy T.M., Noelle R.J., and Green W.R. (1996). Antibody to the ligand for CD40 (gp39) inhibits mouse AIDS (MAIDS) associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J. Virol. 70: 2569-2575.
17. Grewal I.S., and Flavell R.A. (1996). A central role of CD40 ligand in the regulation of CD4+ T cell responses. Immunol. Today 17: 410-414.
18. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway C.A., and Flavell R.A. (1996). Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 237: 1864-1867.
19. Grewal I.S., Xu J., and Flavcll R.A. (1995). Impairment of antigen-specific T cell priming in mice lacking CD40 ligand. Nature 378: 617-620.
20. Hansson G.K. and Libby P. (1996). The role of the lymphocyte. In Atherosclerosis and Coronary Artery disease, Vol. 1, Fuster V., Ross R., and Topol E.J., Eds. (Philadelphia: Lippincott-Raven), pp. 557-568.
21. Hollenbaugh D., Mischel-Petty N., Edwards C.P., Simon J.C., Denfeld R.W., Kiener P.A., and Aruffo A. (1995). Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182: 33-40.
22. Huitinga I., Ruuls S.R., S Jung S., van Rooijen N., Hartung H.P., and Dijkstra C.D. (1995). Macrophages in T cell line mediated, demyelination and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin. Exp. Immunol. 100: 344-351.
23. Kamanaka M., Yu P., Yasui T., Yoshida K., Kawabe T., Horii T., Kishimoto T., and Kishimoto H. (1996). Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4: 275-281.
24. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., and Pober J.S. (1995). CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 92: 4342-4346.
25. Karpus W.J., Lukacs N.W., McRae B.L., Stricter R.M., Kunkel S.L., and Miller S.D. (1995). An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155: 5003-5010.
26. Kato T., Hakamada R., Yamane H., and Nariuchi H. (1996). Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156: 3932-3938.
27. Kiener P.A., Moran-Davis P., Rankin B.M., Wahl A.F., Aruffo A., and Hollenbaugh D. (1995). Stimulation of CD40 with purified soluble gp39 induces pro-inflammatory responses in human monocytes. J. Immunol. 155: 4917-4925.
28. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., and Schuler G. (1996). High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184: 743-746.
29. Laman J.D., Claassen E., and Noelle R.J. (1996). Functions of CD40 and its ligand, gp39. Crit. Rev. Immunol. 16: 59-108.
30. Laman J.D., de Smet B.J.G.L., Schoneveld A., and van Meurs M. (In press, b). CD40-CD40L interactions in atherosclerosis. Immunol. Today.
31. Laman J.D., van Meurs M., Schellekens M.M., de Boer M., Melchers B., Massacesi L., Lassmann H., Claassen E., and 't Hart B.A. (In press, b). Involvement of accessory molecules and cytokines in experimental autoimmune encephalomyelitis (EAE) in marmoset monkeys (Callithrix jacchus). Am. J. Pathol.
32. Leonard J.P., Waldburger K.E., and Goldman S.J. (1995). Prevention of experimental autoimmune encephalomyelitis. J. Exp. Med. 181: 381-386.
33. Libby P., and Ross R. (1996). Cytokines and growth regulatory molecules in atherosclerosis. In Atherosclerosis and Coronary Artery Disease, Vol. 1, Fuster V., Ross R. and Topol E.J., Eds. (Philadelphia: Lippincott-Raven), pp. 585-594.
34. Malik N., Greenfield B.W., Wahl A.F., and Kiener P.A. (1996). Activation of human monocytes through CD40 induces matrix metall oproteinases. J. Immunol. 156: 3952-3960.
35. Massacesi L., Genain C.P., Lee-Parritz D., Letvin N.L., Canfield D., and Hauser S.L. (1995). Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann. Neurol. 37: 519-530.
36. Miltenburg A.M.M., Lacraz S., Welgus H.G., and Dayer J.-M. (1995). Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J. Immunol. 154: 2655-2667.
37. Mohan C., Shi Y., Laman J.D., and Datta S.K. (1995). Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154: 1470-1480.
38. Oxenius A., Campbell K.A., Maliszewski C.R., Kishimoto T., Kikutani H., Hengartner H., Zinkernagel R.M., and Bachmann M.F. (1996). CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4 + T cell functions. J. Exp. Med. 183: 2209-2218.
39. Peng X., Kasran A., Warmerdam P.A.M., de Boer M., and Ceuppens J.L. (1996). Accessory signaling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26: 1621-1627.
40. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., and Kollias G. (1995). Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 92: 11294-11298.
41. Raines E.W., Rosenfield M.E., and Ross R. (1996). The role of macrophages. In Atherosclerosis and Coronary Artery Disease, Vol. 1, Fuster V., Ross R. and Topol E.J., Eds. (Philadelphia: Lippincott-Raven), pp. 539-555.
42. Seder R.A., Kelsall B.L., and Jankovic D. (1996). Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol. 157: 2745-2748.
43. Shu U., Kiniwa M., Wu C.Y., Maliszewski C., Vezzio N., Hakimi J., Gately M., and Delespesse G. (1995). Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25: 1125-1128.
44. Soong L., Xu J., Grewal I.S., Kima P., Sun J., Longley B.J., Ruddle N.H., McMahon-Pratt D., and Flavell R. A. (1996). Disruption of CD40-CD40 ligand interactions results in an enhanced suscep tibility to Leishmania amazonensis infection. Immunity 4: 263-273.
45. Stout R.D., and Suttles J. (1996). The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today 17: 487-492.
46. Stout R.D., Suttles J., Xu J., Grewal I.S., and Flavell R.A. (1996). Impaired T cell macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156: 8-11.
47. Stuber E., Strober W., and Neurath M. (1996). Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183: 693-698.
48. Van Essen D., Kikutani H., and Gray D. (1995). CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378: 620-623.
49. Van Kooten C., and Banchereau J. (1996). CD40-CD40 ligand, a multifunctional receptor-ligand pair. Adv. Immunol. 61: 1-77.
50. Vergelli M., Le H., van Noort J.M., Dhib-Jalbut S., McFarland H., and Martin R. (1996). A novel population of CD4 + CD56 + myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecules. J. Immunol. 157: 679-688.
51. Wagner D.H., Stout R.D., and Suttles J. (1994). Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 24: 3148-3154.
52. Waldburger K.E., Hastings R.C., Schaub R.G., Goldman S.J., and Leonard J.P. (1995). Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin 12. Amer. J. Pathol. 148: 375-382.
53. Wiley J.A., and Harmsen A.G. (1995). CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155: 3525-3529.
54. Yellin M.J., Winikoff S., Fortune S.M., Baum D., Lederman S., and Chess L. (1995). Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukoc. Biol. 58: 209-216.